GlobalData on MSN4 天
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
Yahoo Finance5 天
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s ...
“Continuous subcutaneous apomorphine infusion already has a proven and established 30-year history in Europe, where it has helped deliver more consistent control of motor fluctuations for ...
FiercePharma6 天
Supernus' 4th try proves the charm with long-awaited FDA approval for Parkinson's infusion ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
Morningstar6 天
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s ...
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s disease ONAPGO is a wearable subcutaneous ...
healthday4 天
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
THURSDAY, Feb. 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion ...
U.S. News & World Report4 天
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
THURSDAY, Feb. 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion ...
Nasdaq6 天
Supernus Pharmaceuticals Announces FDA Approval of ONAPGO, the First Subcutaneous ...
Supernus Pharmaceuticals has announced the FDA approval of ONAPGO, the first subcutaneous apomorphine infusion device specifically designed to treat motor fluctuations in adults with advanced ...